|
|
Increasing the health equity and population-level impact of a digital therapeutic for smokers with psychiatric illness |
| 1K02DA054304-01A1 |
|
NIDA |
2022 |
|
|
A Preconception Health Intervention to Reduce Substance Exposed Pregnancies among Incarcerated Women |
| 1K23DA053433-01A1 |
|
NIDA |
2022 |
|
|
Impact of Medicare Part D opioid safety policies on disabled beneficiaries before and during the COVID-19 pandemic |
| 1R01DA055131-01 |
|
NIDA |
2022 |
|
|
Improving MOUD Access, Opioid-Related Outcomes and Equity Among Medicare Beneficiaries with Disability |
| 1R01DA057568-01 |
|
NIDA |
2022 |
|
|
A telehealth tDCS approach to decrease cannabis use: Towards reducing multiple sclerosis disability in multiple sclerosis |
| 1R21DA055427-01 |
|
NIDA |
2022 |
|
|
A pilot study of ambulatory Heart Rate Variability Biofeedback for substance use disorder |
| 1R21DA056468-01 |
|
NIDA |
2022 |
|
|
Deep Brain Stimulation (DBS) For Severe Treatment Refractory Methamphetamine Use Disorder |
| 1UG3DA054746-01A1 |
|
NIDA |
2022 |
|
|
Wearable sensor for opioids detection based on electrochemical sensor arrayintegrated with Bluetooth device |
| 2R44DA051289-02 |
|
NIDA |
2022 |
|
|
Using Augmented Reality illusion therapy to develop a non-opioid chronic pain digital treatment |
| 3R43DA053048-01S1 |
|
NIDA |
2022 |
|
|
Facilitating supervised self-management of stimulant medications among adolescents: improving adherence, reducing stigma, and supporting caregivers |
| 3R43DA053121-01A1S1 |
|
NIDA |
2022 |
